# Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

> **NCT00098917** · PHASE1 · TERMINATED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 15 (—)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** autologous tumor cell vaccine
- **DRUG:** therapeutic autologous dendritic cells
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** biological therapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** surgery
- **PROCEDURE:** tumor cell derivative vaccine
- **PROCEDURE:** vaccine therapy

## Key facts

- **NCT ID:** NCT00098917
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 15 (—)
- **Last updated:** 2008-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00098917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00098917, "Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00098917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*